Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epidural hydroxyethyl starch patch to prevent post-dural puncture headache in parturients
ChiCTR2600133064Phase 4Not yet recruiting
- Sponsor
- Peking University First Hospital
- Start
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of hetastarch in post-dural puncture headache (PDPH), sponsored by Peking University First Hospital. Primary endpoint: Incidence of post-dural puncture headache within 7 days after delivery or cesarean section. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
hetastarch
03
Conditions
post-dural puncture headache (PDPH)
Beyond the preview
Go deeper on ChiCTR2600133064.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600133064.